AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca investments at fair value ($) ($)
Form 11-K Statements of Net Assets Available for Benefits
Latest, FY2025
9,337,281,072
Period ended Dec 31, 2025
Change on a year earlier
+12.0%
8,334,643,410 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Investments at fair value ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 9,337,281,072 | +12.0% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 8,334,643,410 | +14.9% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 7,250,832,374 | – | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca Investments at fair value ($) ($), annual FY2023–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_invest_fv
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.